Surgery and chemotherapy together improved survival in GIST patients with liver metastases, increasing median cancer-specific ...

Breast cancer can spread—or metastasize—to many different parts of the body, but it's not well understood why tumors grow better in some organs than others.

Company closed $22M financing to support randomized Phase 2b trial; IND cleared and study initiated; Interim results anticipated in late 2026; topline data expected in H2/2027 ...

A subgroup analysis of the phase 3 FOCUS study (NCT02678572) shows that the Melphalan/Hepatic Delivery System (HDS; HEPZATO ...

Frederick Bardell died from treatable colon cancer after waiting six months for a colonoscopy, leading a federal judge to ...

A new study co-led by the Southern California Superfund Research and Training Program for PFAS Assessment, Remediation and ...

Two Complete Metabolic Responses (CMRs) observed in patients with relapsed/refractory metastatic Ewing sarcoma and one Complete Response (CR) ...

The cumulative incidence of CRLM has declined, with survival gains mainly in synchronous cases, highlighting the need for ...

The Hepzato Kit is the first FDA-approved liver-directed therapy for unresectable metastatic uveal melanoma, showing ...

Long before a liver tumor appears, a high-fat diet can push liver cells into a risky survival mode. That is the central ...

A redesigned immune-activating cancer drug has produced striking early results in a small clinical trial, shrinking tumors ...

NDA supported by results from a Phase II registration trial in China —— Second most common form of liver cancer after hepatocellular carcinoma, ...